Bone disorders in chronic liver disease (Q36948504)

17 August 2017

1 reference

title

Bone disorders in chronic liver disease (English)

1 reference

17 August 2017

chronic liver disease

0 references

author name string

Jane Collier

series ordinal

1

1 reference

PubMed ID

17886334

17 August 2017

language of work or name

English

0 references

publication date

1 October 2007

1 reference

17 August 2017

1 reference

17 August 2017

46

1 reference

17 August 2017

1271-1278

1 reference

17 August 2017

4

1 reference

Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection

17 August 2017

1 reference

Zoledronic acid prevents bone loss after liver transplantation: a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

21 January 2018

1 reference

7 January 2021

AGA technical review on osteoporosis in hepatic disorders.

1 reference

7 January 2021

Guidelines on the management of osteoporosis associated with chronic liver disease

1 reference

7 January 2021

Immunosuppressive and postoperative effects of orthotopic liver transplantation on bone metabolism

1 reference

7 January 2021

Vitamin D replacement for cirrhosis-related bone disease

1 reference

7 January 2021

Vertebral fractures and osteopenia in chronic alcoholic patients

1 reference

7 January 2021

Metabolic bone disease in alcoholic cirrhosis: a comparison of the effect of vitamin D2, 25-hydroxyvitamin D, or supportive treatment

1 reference

7 January 2021

Hypogonadism is not related to the etiology of liver cirrhosis

1 reference

7 January 2021

Osteoclast differentiation and activation

1 reference

7 January 2021

The RANKL/OPG system and bone mineral density in patients with chronic liver disease.

1 reference

7 January 2021

Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis.

1 reference

7 January 2021

Osteopenia in rats with liver cirrhosis: beneficial effects of IGF-I treatment

1 reference

7 January 2021

Hyperbilirubinemia is not a major contributing factor to altered bone mineral density in patients with chronic liver disease.

1 reference

7 January 2021

Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials

1 reference

7 January 2021

Osteoporosis and skeletal fractures in chronic liver disease

1 reference

7 January 2021

Metabolic bone disease of liver cirrhosis: is it parallel to the clinical severity of cirrhosis?

1 reference

7 January 2021

Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation.

1 reference

7 January 2021

Bone disease in patients with primary sclerosing cholangitis: prevalence, severity and prediction of progression.

1 reference

7 January 2021

Incidence of vertebral fractures in the first three months after orthotopic liver transplantation

1 reference

7 January 2021

Osteopenia and osteoporosis in patients with end-stage liver disease caused by hepatitis C and alcoholic liver disease: Not just a cholestatic problem

1 reference

7 January 2021

Bone mineral density among cirrhotic patients awaiting liver transplantation

1 reference

7 January 2021

Bone mineral density before and after OLT: long-term follow-up and predictive factors.

1 reference

7 January 2021

Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis

1 reference

7 January 2021

Fracture Risk in People With Primary Biliary Cirrhosis: A Population-Based Cohort Study

1 reference

7 January 2021

Bone mineral density in men with genetic hemochromatosis and HFE gene mutation

1 reference

7 January 2021

Decreased bone mineral density after therapy with alpha interferon in combination with ribavirin for chronic hepatitis C.

1 reference

7 January 2021

Bone metabolism and gonad function in male patients undergoing liver transplantation: a two-year longitudinal study.

1 reference

7 January 2021

Treatment of bone disorders in liver disease

1 reference

7 January 2021

Calcitriol for bone loss in patients with primary biliary cirrhosis.

1 reference

7 January 2021

Alendronate improves bone mineral density in primary biliary cirrhosis: a randomized placebo-controlled trial

1 reference

7 January 2021

Osteonecrosis of the jaw and bisphosphonates

1 reference

7 January 2021

Transdermal hormone replacement therapy improves vertebral bone density in primary biliary cirrhosis: results of a 1-year controlled trial.

1 reference

7 January 2021

Osteoporosis in Primary Biliary Cirrhosis: A Randomized Trial of the Efficacy and Feasibility of Estrogen/Progestin

1 reference

7 January 2021

An open, randomized, controlled study of transdermal hormone replacement therapy on the rate of bone loss in primary biliary cirrhosis

1 reference

7 January 2021

Raloxifene improves bone mass in osteopenic women with primary biliary cirrhosis: results of a pilot study

1 reference

7 January 2021

Bone loss after orthotopic liver transplantation

1 reference

7 January 2021

Intravenous bisphosphonate prevents symptomatic osteoporotic vertebral collapse in patients after liver transplantation.

1 reference

7 January 2021

Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.21852

1 reference

17 August 2017

1 reference

PubMed ID

17886334